Randall F. Holcombe, M.D., M.B.A., director of the UVM Cancer Center and chief of the Division of Hematology and Oncology in the Department of Medicine, has been appointed as associate dean for cancer programs at the UVM Larner College of Medicine.
Randall F. Holcombe, M.D., M.B.A. (Photo: David Seaver)
Richard L. Page, M.D., dean of Larner College of Medicine at the University of Vermont, has announced the appointment of Randall F. Holcombe, M.D., M.B.A., as associate dean for cancer programs.
In August of 2021 Holcombe came to UVM to serve in the dual roles of director of the UVM Cancer Center and chief of the Division of Hematology and Oncology in the Department of Medicine. Since then, he has re-energized the UVM Cancer Center by fostering laboratory and population-based research, investing in new educational programs, supporting a cancer practice with over 32,000 yearly patient visits, and launching initiatives that engage the broader community. These accomplishments, along with many other efforts now underway in partnership with the UVM Health Network, contribute to the important goal of securing National Cancer Institute re-designation for the UVM Cancer Center.
Holcombe’s distinction was recognized in the fall of 2021 when he was named the inaugural J. Walter Juckett Chair in Cancer Research at our College. This chair was endowed by the J. Walter Juckett Cancer Research Foundation, an organization that has provided extensive support to our Cancer Center for more than four decades.
“This associate deanship recognizes the important place cancer research, care, community outreach, and education hold in the landscape of our college’s mission,” said Dean Page. “I hope our entire community will join me in thanking Dr. Holcombe for all that he has accomplished thus far and extend best wishes to him in his new additional role at our institution.”